ATLANTA, GA / ACCESSWIRE / December 7, 2022 / Holzer & Holzer, LLC informs investors that a class action lawsuit was filed against Veru Inc. ("Veru" or the "Company") (NASDAQ:VERU). The lawsuit alleges Veru made materially false and misleading statements and/or failed to disclose material adverse facts about data from a Phase 3 clinical trail for the Company's drug, sabizabulin, and about Veru's interactions with the FDA. Specifically, Veru mislead shareholders to believe its Phase 3 data was sufficient to support an Emergency Use Authorization ("EUA") and even a New Drug Application ("NDA") without further studies.
If you bought shares of Veru between May 11, 2022 and November 9, 2022, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey Holzer, Esq. at [email protected] or Joshua Karr, Esq. at [email protected], by toll-free telephone at (888) 508-6832 or you may visit the firm's website at https://holzerlaw.com/case/veru/ to learn more.
The deadline to ask the court to be appointed lead plaintiff in the case is February 6, 2023.
Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, www.holzerlaw.com, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.
CONTACT:
Corey Holzer, Esq.
(888) 508-6832 (toll-free)
SOURCE: Holzer & Holzer